We are live on ! Find out more
TLP

Tri Locum Partners Portfolio holdings

AUM $713M
1-Year Est. Return 68.92%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+68.92%
3 Year Est. Return
+377.81%
5 Year Est. Return
+1,289.15%
10 Year Est. Return
–
AUM
$713M
AUM Growth
-$57.6M
Cap. Flow
-$67.5M
Cap. Flow %
-9.48%
Top 10 Hldgs %
81.58%
Holding
21
New
6
Increased
3
Reduced
8
Closed
4

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$77.5M
2
TMO icon
Thermo Fisher Scientific
TMO
+$71.9M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$60.3M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$27.7M
5
DXCM icon
DexCom
DXCM
+$19.3M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$79.4M
2
BSX icon
Boston Scientific
BSX
+$49.6M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$44.1M
4
JNJ icon
Johnson & Johnson
JNJ
+$43.9M
5
VERA icon
Vera Therapeutics
VERA
+$40.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%

No holdings matched the selected filter criteria.

Similar funds

DCM
Defilade Capital Management Emeryville, California $712M AUM
AMPWP
Alvarez & Marsal Private Wealth Partners West Palm Beach, Florida $712M AUM
DCM
Dimension Capital Management Coral Gables, Florida $713M AUM 18.57% 1-Year Est. Return
IWP
Insight Wealth Partners Plano, Texas $713M AUM 16.55% 1-Year Est. Return
PCS
Personal CFO Solutions Chester, New Jersey $712M AUM 25.3% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
ECM
EagleClaw Capital Management Boston, Massachusetts $714M AUM 24.24% 1-Year Est. Return

Tri Locum Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Tri Locum Partners held 21 positions worth $713M, down 7.5% from $770M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Tri Locum Partners withdrew a net $67.5M in Q1 2026, closing 4 positions and reducing 8 holdings. Its most notable exit was Danaher, an estimated $79.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Tri Locum Partners opened a new position in Intuitive Surgical worth $70.6M.

  • Tri Locum Partners's largest Q1 2026 buy was Intuitive Surgical: 153,250 shares worth $70.6M.
  • Tri Locum Partners added most to DexCom in Q1 2026, an estimated $19.3M increase.
  • Tri Locum Partners's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $43.9M.
  • Tri Locum Partners fully exited Danaher in Q1 2026, selling an estimated $79.4M.
  • Tri Locum Partners's ten largest holdings make up 82% of its $713M portfolio in Q1 2026.
  • Tri Locum Partners opened 6 new positions and closed 4 in Q1 2026.
  • Tri Locum Partners's portfolio value fell 7.5% quarter-over-quarter to $713M.

Based on Tri Locum Partners's 13F filing for Q1 2026, filed 18 May 2026.